SureTrader
Home > Boards > US OTC > Biotechs > CYTODYN INC (CYDY)

I don't disagree with you at all, ahab.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BlackDoggie Member Profile
 
Followed By 9
Posts 543
Boards Moderated 0
Alias Born 02/17/17
160x600 placeholder
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 2/23/2018 5:23:20 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 4:42:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 4:39:35 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/20/2018 6:33:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 6:33:16 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:04:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:02:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2018 6:01:53 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/14/2018 12:22:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 4:38:32 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 2/7/2018 4:53:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/7/2018 4:34:05 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/31/2018 4:43:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/31/2018 4:38:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2018 4:34:56 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/25/2018 4:35:52 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/23/2018 8:14:51 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/23/2018 8:03:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2018 7:51:29 AM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/10/2018 5:01:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2018 4:56:01 PM
Amended Tender Offer Statement by Issuer (sc To-i/a) Edgar (US Regulatory) - 1/8/2018 4:37:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/8/2018 4:36:15 PM
BlackDoggie   Friday, 11/10/17 04:32:36 PM
Re: ahab333 post# 18104
Post # of 20401 
I don't disagree with you at all, ahab. My suggestion is that requiring an additional 10 easily accessible (if you believe CC timelines) as a stall tactic by the FDA wouldn't be all that effective. That's what makes me think that this was something different altogether. If they FDA wanted to seriously stall, then they require another 30, or don't accept the current 40, or require a new trial... Stalling things by a couple weeks isn't exactly a coup de gras.

My opinion, of course.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist